Merck KGaA (OTCMKTS:MKKGY) Upgraded at HSBC

HSBC upgraded shares of Merck KGaA (OTCMKTS:MKKGY) to a hold rating in a research report sent to investors on Monday,Zacks.com reports.

MKKGY has been the topic of a number of other research reports. Jefferies Financial Group began coverage on shares of Merck KGaA in a report on Tuesday, May 26th. They issued a “hold” rating on the stock. Sanford C. Bernstein raised shares of Merck KGaA to a “hold” rating in a report on Thursday, March 19th. Six analysts have rated the stock with a Hold rating, According to MarketBeat.com, Merck KGaA has an average rating of “Hold”.

Merck KGaA Stock Performance

OTCMKTS:MKKGY opened at $31.98 on Monday. The business’s 50-day moving average price is $30.14 and its two-hundred day moving average price is $28.73. Merck KGaA has a twelve month low of $23.73 and a twelve month high of $34.19. The stock has a market cap of $20.66 billion, a P/E ratio of 14.21, a PEG ratio of 2.85 and a beta of 1.00. The company has a quick ratio of 1.00, a current ratio of 1.51 and a debt-to-equity ratio of 0.36.

Merck KGaA (OTCMKTS:MKKGY) last announced its earnings results on Wednesday, May 13th. The company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.14. Merck KGaA had a net margin of 12.07% and a return on equity of 8.79%. The business had revenue of $6.03 billion for the quarter, compared to the consensus estimate of $5.93 billion. As a group, equities analysts predict that Merck KGaA will post 1.87 EPS for the current fiscal year.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.